Evidence map›Paper›PMID 37338866›Full record

ArticleJAMA2023

Screening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statement.

US Preventive Services Task Force, Michael J Barry, Wanda K Nicholson, Michael Silverstein, Tumaini Rucker Coker, Karina W Davidson, Esa M Davis, Katrina E Donahue, Carlos Roberto Jaén, Li Li and 8 more

Abstract read
PubMed Publisher
In one paragraph

Article in JAMA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Psychosocial challenges with transplantation.Current opinion in pulmonary medicine · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Barriers and Facilitators to Screening for Anxiety and Intimate Partner Violence.Journal of the American Board of Family Medicine : JABFM · 2026
    Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Internalizing Psychiatric Symptoms in People With Mosaicism for Trisomy 21.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2025
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

US Preventive Services Task Force
Michael J BarryHarvard Medical School, Boston, Massachusetts.
Wanda K NicholsonGeorge Washington University, Washington, DC.
Michael SilversteinBrown University, Providence, Rhode Island.
Tumaini Rucker CokerUniversity of Washington, Seattle.
Karina W DavidsonFeinstein Institutes for Medical Research at Northwell Health, Manhasset, New York.
Esa M DavisUniversity of Pittsburgh, Pittsburgh, Pennsylvania.
Katrina E DonahueUniversity of North Carolina at Chapel Hill.
Carlos Roberto JaénThe University of Texas Health Science Center, San Antonio.
Li LiUniversity of Virginia, Charlottesville.
Gbenga OgedegbeNew York University, New York, New York.
Lori PbertUniversity of Massachusetts Medical School, Worcester.
Goutham RaoCase Western Reserve University, Cleveland, Ohio.
John M RuizUniversity of Arizona, Tucson.
James StevermerUniversity of Missouri, Columbia.
Joel TsevatThe University of Texas Health Science Center, San Antonio.
Sandra Millon UnderwoodUniversity of Wisconsin, Milwaukee.
John B WongTufts University School of Medicine, Boston, Massachusetts.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Anxiety disorders are commonly occurring mental health conditions. They are often unrecognized in primary care settings and substantial delays in treatment initiation occur. Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for anxiety disorders in asymptomatic adults. Population: Asymptomatic adults 19 years or older, including pregnant and postpartum persons. Older adults are defined as those 65 years or older. Evidence Assessment: The USPSTF concludes with moderate certainty that screening for anxiety disorders in adults, including pregnant and postpartum persons, has a moderate net benefit. The USPSTF concludes that the evidence is insufficient on screening for anxiety disorders in older adults. Recommendation: The USPSTF recommends screening for anxiety disorders in adults, including pregnant and postpartum persons. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety disorders in older adults. (I statement).

Indexed as

AnxietyMass ScreeningAgedAnxiety DisordersFearFemaleHumansPregnancyPreventive Health Services

Identifiers

PMID37338866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.